Delivery Order SPE2DB24D2205-SPE2DB24FEAFJ

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of FLAREX 0.1% eye drops (5 ml) to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,774.46, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,646.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLAREX 0.1% eye drops, a pharmaceutical product, with a completion date of February 6, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,185.54, is a Firm Fixed Price Delivery Order for the supply of FLAREX 0.1% eye drops in 5ml units. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FLAREX 0.1% eye drops. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,878.33 and an ultimate completion date of June 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,460.32 firm fixed-price delivery order is for FLAREX 0.1% eye drops, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,356.51 firm fixed price delivery order is for the supply of FLAREX 0.1% eye drops, a specialty ophthalmic medication. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this order as well as other indefinite delivery contracts (IDCs) by the DLA and Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,838.84 firm fixed-price delivery order is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product used for ophthalmic treatment. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen is the prime contractor and there are no set-aside requirements indicated. The company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,194.38, is for the delivery of FLAREX 0.1% eye drops (5 ml) to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,821.70 delivery order covers the procurement of FLAREX 0.1% eye drops, a specialty ophthalmic medication, with a completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FLAREX 0.1% eye drops. The award has a ceiling value of $7,019.88 and is a firm fixed-price contract with an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing this critical medical product to support the healthcare needs of military treatment facilities and other federal healthcare providers. This...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FEAFJ
    Delivery Order

This federal contract award is for the supply of FLAREX 0.1% eye drops, 5 mL, to the Defense Logistics Agency (DLA). The $8,371.50 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 2025 for delivering a range of medical commodities to support military treatment programs and facilities worldwide. This award is not set aside for any specific business category.

Generated 12/20/24, 9:30 AM